RxDoctor Payments Data

Laura Wilson

Acute Care · El Paso, TXNPI 1477984615

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $25,140 of the $31,685 with a category attached, or 79.3%. Medtronic accounts for 63.6% of it on its own, with 17 other manufacturers making up the rest. Among acute care clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$31,685in general payments, 2019–2025

Across 584 payments — averaging $54.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$20K
  • Abbott$3K
  • Shockwave Medical, Inc$2K
  • Abiomed$2K
  • Inari Medical, Inc.$1K
  • Edwards Lifesciences$1K
  • plus $2K from 12 others

What the payments were for

  • Travel & lodging$6,43720%
  • Food & beverage$25,14079%
  • Education$1080%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,685 in reported general payments places this provider in the 95th percentile of 2,323 acute care providers in Texas.

See all acute care providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor53$28,097
FarxigaDapagliflozin Propanediol39$27,927
EliquisApixaban25$20,841
EntrestoSacubitril/Valsartan19$13,019
Ranolazine ErRanolazine13$959
Atorvastatin Calcium62$630
ClopidogrelClopidogrel Bisulfate88$608
Metoprolol Succinate52$582
Prasugrel Hcl14$565
Losartan Potassium45$510
Rosuvastatin Calcium35$409
Amiodarone Hcl20$232
Spironolactone41$214
Amlodipine Besylate26$145
Cephalexin27$143

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBrilinta, Farxiga$453$56,02592 claims
NovartisEntresto$553$13,01919 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,323 acute care providers in Texas.

Other acute care in El Paso

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →